Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
(NASDAQ: RZLT) Delayed: 5.17 +0.02 (0.39%)
Previous Close $5.15    52 Week High $ 
Open $5.04    52 Week Low $ 
Day High $5.26    P/E N/A 
Day Low $5.02    EPS $ 
Volume 636,840